Evidence map›Paper›PMID 39652873›Full record

ArticleAnnals of internal medicine2025

Development and Evaluation of a Comprehensive Prediction Model for Incident Coronary Heart Disease Using Genetic, Social, and Lifestyle-Psychological Factors: A Prospective Analysis of the UK Biobank.

Mohammadreza Naderian, Kristjan Norland, Daniel J Schaid, Iftikhar J Kullo

Abstract read
In one paragraph

Article in Annals of internal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Genetic risk disclosure and behavioural change: not so fast.European journal of preventive cardiology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammadreza NaderianDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota (M.N., K.N.).ORCID 0000-0003-1827-3173
Kristjan NorlandDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota (M.N., K.N.).
Daniel J SchaidDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota (D.J.S.).
Iftikhar J KulloDepartment of Cardiovascular Medicine and Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota (I.J.K.).

Funding

Genomic Basis of Susceptibility to COVID-19 Infection and its ComplicationsU01HG006379 · NHGRI · MAYO CLINIC ROCHESTER · PI Richard R. Sharp · 2011 to 2026
$16.5M
Polygenic Risk of Disease in Populations of Diverse AncestryU01HG011710 · NHGRI · MAYO CLINIC ROCHESTER · PI SCHAID, DANIEL J. · 2021 to 2025
$3.2M
Quantitative Methods for Genetic EpidemiologyR35GM140487 · NIGMS · MAYO CLINIC ROCHESTER · PI SCHAID, DANIEL J. · 2021 to 2025
$1.9M
NHGRI NIH HHS U01 HG006379NHGRI NIH HHS U01 HG011710NIGMS NIH HHS R35 GM140487
6 · The paper itself

Abstract

backgroundClinical risk calculators for coronary heart disease (CHD) do not include genetic, social, and lifestyle-psychological risk factors.

objectiveTo improve CHD risk prediction by developing and evaluating a prediction model that incorporated a polygenic risk score (PRS) and a polysocial score (PSS), the latter including social determinants of health and lifestyle-psychological factors.

designCohort study.

settingUnited Kingdom.

participantsUK Biobank participants recruited between 2006 and 2010. MEASUREMENTS: Incident CHD (myocardial infarction and/or coronary revascularization); 10-year clinical risk based on pooled cohort equations (PCE), Predicting Risk of cardiovascular disease EVENTs (PREVENT), and QRISK3; PRS (Polygenic Score Catalog identification: PGS000018) for CHD (PRS

resultsIn 388 224 participants (age, 55.5 [SD, 8.1] years; 42.5% men; 94.9% White), the hazard ratio for 1 SD increase in PSS LIMITATION: A predominantly White cohort; possible healthy participant effect and ecological fallacy.

conclusionA PSS PRIMARY FUNDING SOURCE: National Human Genome Research Institute.

Indexed as

Coronary DiseaseLife StyleAdultAgedBiological Specimen BanksFemaleHumansIncidenceMachine LearningMaleMiddle AgedMultifactorial InheritanceProspective StudiesRisk AssessmentUK BiobankUnited Kingdom

Identifiers

PMID39652873
PMCPMC12063737

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.